Dr. Jared Weiss is a medical oncologist and the Section Chief of Thoracic and Head/Neck Oncology at the UNC School of Medicine and the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. He specializes in lung cancer, squamous head and neck cancer, and other cancers, including pleural mesothelioma, with a focus on the
Dr. Chad Pecot is a thoracic medical oncologist and physician-scientist at the University of North Carolina and Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. He specializes in lung cancer and abnormal tumors inside the chest, including pleural mesothelioma. As a former cancer patient, he strives to rapidly bring research innovations into clinical practice.
Dr. Carrie Lee is a medical and thoracic oncologist at the University of North Carolina at Chapel Hill and a Professor at the UNC School of Medicine. Her clinical practice focuses on lung cancer, and she has experience with traditional chemotherapy protocols as well as novel regimens. She is also the Chief Medical Officer for UNC
A just-released study conducted in the Netherlands provides a mixed assessment of the use of nivolumab-ipilimumab immunotherapy in patients with malignant pleural mesothelioma. While researchers found that the real-world efficacy of the combination was comparable to what was reported in a phase 3 study, they also reported that toxicities – particularly among elderly patients –
Dr. William Petty is a medical oncologist and hematologist in the department of Medical Oncology at the Wake Forest Medical Center. As Director of the Thoracic Oncology program, he specializes in treating patients diagnosed with lung cancer and malignant pleural mesothelioma. Education and Career Dr. Petty earned his Bachelor of Arts degree at Harvey Mudd
A group of researchers from cancer centers in Vienna has announced that they’ve identified a therapeutic target that, when inhibited, enhances mesothelioma tumors’ sensitivity to chemotherapy and radiotherapy. The group believes that this approach may yield a novel and effective treatment approach for the rare, asbestos-related disease.
Dr. Clarke is a medical oncologist at the Duke Cancer Institute in Durham, North Carolina. He specializes in treating patients with thoracic cancers, including pleural mesothelioma and lung cancer. He says that the most rewarding part of his work is developing long-term relationships with his patients and their families throughout their cancer journeys. Education and
Dr. Tong is a thoracic surgeon and surgical oncologist with Duke Health in Raleigh and Durham, North Carolina. Her focus is on thoracic oncology and minimally invasive thoracic surgery, and her clinical expertise is in lung and esophageal cancer surgery as well as surgery for the treatment of pleural mesothelioma. She has achieved international prominence
One of the most challenging aspects of pursuing a mesothelioma or asbestos-related lung cancer lawsuit is the significant gap between when the victim’s exposure took place and when their illness is diagnosed. It’s hard for anybody to remember details from four or five decades earlier, and this is especially true when fighting a fatal disease.
Dr. Abraham Chachoua is a thoracic oncologist and the Director of the Lung Cancer Center at the Perlmutter Cancer Center of NYU Langone. He specializes in treating thoracic cancers, including lung cancer and pleural mesothelioma. A recognized leader in lung cancer therapy, Dr. Chachoua became interested in the field of medicine, particularly in oncology, after